CI
The startup has developed a platform utilizing microscopic glass microspheres that are injected into the bloodstream to target joint pain from osteoarthritis. This method blocks pain receptors and provides a drug-free alternative for long-term relief, as the microspheres dissolve completely after treatment.
Updated 18 months ago
Funding
$950K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
AC
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a platform utilizing microscopic glass microspheres that are injected into the bloodstream to target joint pain from osteoarthritis. This method blocks pain receptors and provides a drug-free alternative for long-term relief, as the microspheres dissolve completely after treatment.